<DOC>
	<DOCNO>NCT01082705</DOCNO>
	<brief_summary>Following rapid development significant drug resistance chloroquine sulfadoxine-pyrimethamine ( first line therapy Tanzania 2001 -2006 ) , artemether- lumefantrine ( Coartem AL ) adopt first line therapy Tanzania 2006 . Now drug widely use time , investigator propose conduct antimalarial efficacy trial monitor effectiveness therapy , determine drug remain efficacious , significant resistance emerge , case new antimalarial strategy need contemplate . The investigator hypothesize efficacy Artemether-lumefantrine remain high , artemisinin combination therapy equally efficacious . Children 6-59 month age symptomatic malaria randomly assign treat either artemether + lumefantrine ( Coartem ) dihydroartemisinin-piperaquine ( Duo-Cotecxin Artekin ) . Clinical , parasitologic , hematologic parameter monitor 42-day follow-up period use evaluate drug efficacy .</brief_summary>
	<brief_title>Assessing Efficacy Artemisinin Combination Therapies Treatment Uncomplicated Malaria Infection Children</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<mesh_term>Artemisinine</mesh_term>
	<criteria>1 . Age 659 month 2 . Axillary temperature ≥ 37.5º C history fever past 48 hour 3 . Weight ≥ 5.0 kg 4 . Slideconfirmed infection P. falciparum , parasitemia 2,000200,000 asexual form per μl 5 . Live within boundary officially recognize catchment area Miono Health Center . 6 . Caregiver agree blood draw return visit . 1 . General danger sign symptom severe malaria 2 . Signs symptom severe malnutrition , define weightforage ≤ 3 standard deviation mean ( National Center Health Statistics [ NCHS ] /World Health Organization [ WHO ] normalize reference value ) 3 . Slide confirm infection Plasmodium spp . besides falciparum mixed plasmodium infection 4 . Severe anemia , define Hb &lt; 5 g/dl 5 . Known hypersensitivity drug test 6 . Presence febrile condition cause disease malaria 7 . Serious chronic medical condition ( heart failure , sickle cell disease ) . 8 . Plan travel leave area within next 3 month . 9 . Have treat malaria 2 week prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>malaria</keyword>
	<keyword>treatment</keyword>
	<keyword>artemisinin combination therapy</keyword>
	<keyword>Tanzania</keyword>
	<keyword>P. falciparum malaria child age 6-59 month</keyword>
</DOC>